Physician profile
Roger Desprez
NPI 1154391993
$3,668.61
in general payments reported to CMS, 2019-2025
8 companies · $28.73 in 2025
The $28.73 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,855 · 2020: $568 · 2021: $93.44 · 2022: $585 · 2023: $188 · 2024: $351 · 2025: $28.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519 · Travel and Lodging: $48.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $518.52 |
| Travel and Lodging | $48.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $2,082.70 | 2019-2024 | Ffrct |
| Siemens Medical Solutions USA, INC. | $778.77 | 2019 | |
| Ge Healthcare | $604.63 | 2019-2024 | |
| Medtronic Vascular, INC. | $124.65 | 2019 | |
| Cleerly, INC. | $28.73 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Pfizer INC. | $19.31 | 2023 | |
| Janssen Pharmaceuticals, INC | $16.42 | 2019 | |
| Boston Scientific Corporation | $13.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Desprez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.